# Pharmacokinetics and Pharmacodynamics of Different PTG-300 Regimens in Healthy Volunteers

> **NCT04516382** · PHASE1 · COMPLETED · sponsor: **Protagonist Therapeutics, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** PTG-300

## Key facts

- **NCT ID:** NCT04516382
- **Lead sponsor:** Protagonist Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-14
- **Primary completion:** 2021-01-12
- **Final completion:** 2021-06-30
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04516382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04516382, "Pharmacokinetics and Pharmacodynamics of Different PTG-300 Regimens in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04516382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*